NASDAQ:KEQU
Kewaunee Scientific Corp.
Kewaunee Scientific Corp.'s revenue grew 17.3% in fiscal 2026 to $282.0M while operating margin fell to 5.9%. Free cash flow was $14.7M, 5.2% of revenue.Summary generated from Kewaunee Scientific Corp.'s SEC filings. Latest annual report filed Jun 26, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$282.0M
Revenue growth+17.3%
Revenue, 5-yr CAGR+13.8%
Gross margin28.5%
Operating margin5.9%
Net margin3.4%
ROIC14.7%
Return on equity13.8%
Debt / equity0.27
Free cash flow$14.7M
FCF margin5.2%
Share count change+0.1%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 169 | 219 | 204 | 240 | 282 |
| Operating income | −3 | 5 | 18 | 18 | 17 |
| Net income | −6 | 1 | 19 | 11 | 10 |
| Free cash flow | −10 | −8 | 15 | 13 | 15 |
Recent filings
- 10-QQuarterly report for the period ended Jul 31, 2026
Sep 11, 2026 - 8-KResults of operations and financial condition
Sep 9, 2026 - 8-KResults of a shareholder vote
Aug 27, 2026 - 8-KRegulation FD disclosure
Aug 26, 2026 - 8-KOther events
Aug 25, 2026 - DEF 14AProxy statement
Jul 7, 2026 - 4Insider transaction report
Jul 2, 2026 - 4Insider transaction report
Jul 2, 2026